Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)

Completed · Not applicable

Conditions studied: Asthma

In brief

Inhaled corticosteroids (ICS) are considered first-line treatment for persistent asthma, yet little is known about the genetic factors that influence response to this therapy. This study seeks to quantify response to ICS therapy in African American and white patients, as well as look for genetic markers that predict treatment response.

Key facts

Study ID
NCT01142947
Run by
Henry Ford Health System
People needed
362
Starts
2007-10-01
Expected to finish
2019-03-11
Last updated by the study team
2019-04-02

Who can join

Age: 12 and older, up to 56. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.